Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial

  1. Wei, F.-F.
  2. Pellicori, P.
  3. Ferreira, J.P.
  4. González, A.
  5. Mariottoni, B.
  6. An, D.-W.
  7. Verdonschot, J.A.J.
  8. Liu, C.
  9. Ahmed, F.Z.
  10. Petutschnigg, J.
  11. Rossignol, P.
  12. Heymans, S.
  13. Cuthbert, J.
  14. Girerd, N.
  15. Clark, A.L.
  16. Li, Y.
  17. Nawrot, T.S.
  18. Díez, J.
  19. Zannad, F.
  20. Cleland, J.G.F.
  21. Staessen, J.A.
  22. Zannad, F.
  23. Wei, F.-F.
  24. Verdonschot, J.A.J.
  25. Thijs, L.
  26. Ravassa, S.
  27. Rouet, P.
  28. Rossignol, P.
  29. Pellicori, P.
  30. Pieske, B.
  31. Pizard, A.
  32. Mamas, M.A.
  33. Moreno, M.U.
  34. Maestre, G.E.
  35. McDonald, K.
  36. Latini, R.
  37. López, B.
  38. Khan, J.
  39. Hansen, T.W.
  40. Heymans, S.
  41. Hazebroek, M.
  42. Grojean, S.
  43. Girerd, N.
  44. Ferreira, J.P.
  45. Edelmann, F.
  46. Díez, J.
  47. Collier, T.
  48. Cleland, J.G.F.
  49. Cosmi, F.
  50. Brunner La Rocca, H.P.
  51. Bozec, E.
  52. Asayama, K.
  53. Mostrar todos os autores +
Revista:
Hypertension Research

ISSN: 1348-4214,  0916-9636

Ano de publicación: 2024

Tipo: Artigo

DOI: 10.1038/S41440-024-01843-Z GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus